| Direct Competitor Comparison | |
|---|
| PFE | MRK | NVS | SNY | Industry |
|---|
| Market Cap: | 206.20B | 143.99B | 176.97B | 141.36B | 64.52B |
|---|
| Employees: | 89,400 | 83,000 | 129,000 | 111,974 | 99.49K |
|---|
| Qtrly Rev Growth (yoy): | -0.09 | -0.09 | 0.02 | -0.09 | 0.11 |
|---|
| Revenue (ttm):
| 57.60B | 46.21B | 57.80B | 45.54B | 27.01B |
|---|
| Gross Margin (ttm): | 0.81 | 0.65 | 0.68 | 0.69 | 0.61 |
|---|
| EBITDA (ttm): | 25.34B | 16.36B | 17.15B | 15.16B | 10.37B |
|---|
| Operating Margin (ttm):
| 0.32 | 0.21 | 0.22 | 0.20 | 0.16 |
|---|
| Net Income (ttm): | 10.52B | 6.02B | 9.66B | 5.39B | N/A |
|---|
| EPS (ttm): | 2.09 | 1.96 | 3.94 | 2.03 | 3.27 |
|---|
| P/E (ttm): | 13.99 | 24.42 | 18.32 | 26.39 | 14.20 |
|---|
| PEG (5 yr expected): | 4.82 | 4.49 | 2.62 | 2.07 | 0.96 |
|---|
| P/S (ttm): | 3.62 | 3.12 | 3.11 | 3.17 | 2.23 |
|---|
|
| MRK = Merck & Co. Inc. | | NVS = Novartis AG | | SNY = Sanofi | | Industry = Drug Manufacturers - Major | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 99.90 | -0.02 | 74.59B | 16.91 |
|---|
| Genentech, Inc. | Private |
|---|
| Biogen Idec Inc. | BIIB | 205.24 | -0.03 | 48.44B | 32.57 |
|---|
| Genzyme Corporation | Private |
|---|
| Merck Serono S.A. | Private |
|---|
| Gilead Sciences Inc. | GILD | 50.99 | -0.02 | 77.35B | 28.55 |
|---|
| MedImmune, L.L.C. | Private |
|---|
| Life Technologies Corporation | LIFE | 74.18 | -0.00 | 12.77B | 31.40 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 39.30 | -0.01 | 33.48B | 19.62 |
|---|
| Sandoz International GmbH | Private |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 124.13 | -0.01 | 15.82B | N/A |
|---|
| Ranbaxy Laboratories Limited | Private |
|---|
| Mylan, Inc. | MYL | 31.50 | -0.01 | 11.95B | 21.04 |
|---|
| Pfizer Inc. | PFE | 29.24 | -0.01 | 206.20B | 13.99 |
|---|
| Johnson & Johnson | JNJ | 85.18 | -0.01 | 238.61B | 23.13 |
|---|
| GlaxoSmithKline plc | GSK | 51.65 | -0.02 | 124.79B | 18.88 |
|---|
| Sanofi | SNY | 53.54 | -0.02 | 141.36B | 26.39 |
|---|
| Novartis AG | NVS | 72.20 | -0.01 | 176.97B | 18.32 |
|---|
| Roche Holding AG | RHHBY | 61.99 | -0.01 | 210.39B | 20.75 |
|---|
| AstraZeneca PLC | AZN | 50.34 | -0.01 | 62.81B | 11.13 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 36.46 | -0.03 | 56.54B | 11.11 |
|---|
| Bristol-Myers Squibb Company | BMY | 46.33 | -0.01 | 75.78B | 52.47 |
|---|
|
| News on Direct Competitors | |
|---|
- SNY
- Is a Type 1 Diabetes Cure Right Around the Corner? at Motley Fool Wed 1:50pm
- NVS
- David Pyott Isn't Just A Pretty Face At Allergan at Investor's Business Daily Wed 1:49pm
- SNY
- The Diabetes Drug War at Motley Fool Wed 10:46am
- SNY
- What Do These Factors Suggest About Elan Stock? at Wall St. Cheat Sheet Tue 2:05pm
- SNY
- CryoPort's Game-Changer In Frozen Biological Shipping at Seeking Alpha Tue 12:54pm
- SNY
- Good News for InterMune Zacks Mon, Jun 17
- NVS
- PDL BioPharma wants arbitration in royalty dispute AP Tue, Jun 11
- NVS
- Questcor will pay at least $135M for Novartis drug AP Tue, Jun 11
- MRK
- News Summary: Drug news ups Merck, Bristol stocks AP Mon, Jun 3
- MRK
- Shares of Merck, Bristol jump on cancer drug news AP Mon, Jun 3
- NVS
- Receptos rises as analysts start coverage AP Mon, Jun 3
- MRK
- GSK bets on chimp virus with $321 million vaccines buy Reuters Wed, May 29
- MRK
- Sector Snap: Analysts expect pharma restructuring AP Tue, May 28
- NVS
- Valeant to buy Bausch + Lomb for $8.7B AP Tue, May 28
- MRK
- Merck ends development of Parkinson's disease drug AP Thu, May 23
All Headlines for these symbols... Currency in USD. | |
|
0.49%